News | June 21, 2026
LabGenius and LG Chem strike AI-powered deal to develop next-gen tumour-targeting antibody therapy
The collaboration is focused on overcoming a major limitation in existing cancer drugs
The collaboration is focused on overcoming a major limitation in existing cancer drugs
The approval clears the company to market a generic version that is therapeutically equivalent to Retin-A Cream
Molbio Diagnostics' Truenat HPV-HR Plus becomes the world's first formally validated reduced-valency HPV test, meeting WHO-IARC standards
Dr. Quirk said the program’s mechanism offers a targeted approach to disrupted brain signaling in compulsivity-related disorders
SENS study to assess feasibility, effectiveness and family experience of introducing SMA screening into the NHS newborn screening programme
Pharmaceutical R&D veteran brings over 20 years of expertise in formulation development, ANDA filings, and regulated-market product innovation to strengthen MSN Laboratories’ global growth ambitions
Funding will support the expansion of Remidio’s Oculomics platform to identify early signs of pre-eclampsia, anemia and gestational diabetes through retinal imaging, targeting underserved communities
Veteran healthcare leader to oversee operations across Tamil Nadu and Kerala, driving growth and operational excellence
Veteran pharmaceutical executive to relocate to Saudi Arabia and spearhead Cipla’s growth strategy across the Middle East region
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
